Therapeutic Plasma Exchange, Rituximab and IV Ig for Severe Acute Exacerbation of IPF Admitted in ICU
Clinical trial NCT03584802 · TERMINATED
Trial details
- NCT number
- NCT03584802
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2019-11-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.